Reports in adults suggest impaired hypothalamic control of prolactin(PRL)secretion in massive obesity. We investigated 1 2 o b e s e ( D ) p t s ( 8 f e m a l e s , 4 m a l e s ; 1 2~1 . 3 yrs,MfSE, all 100% above IBW and 7 control(C)subjects (4females,3males;l3f1.1yrs; all had weight ages i height ages)with IV Insulin(IV1T)and IV TRH(1VTT)tests Serial PRL,growth hormone(IRGH),insulin(IRI),blood sugar(BS),cortisol(F),g1ucagon(IRG),TSH,T T3,by RIA were obtained. 0 showed no diffefences from C in the basal and BS nadir, basal and peak IRG, F,and thyroid responses to both tests. Basal IRI .levels were higher, 36i9.4 vs 10&2.3uU/ml, p<O.O5;peak IRGH responses after IET were lower than in C, 6.l*l-l= 12.7*3.7ng/ ml, pC0.05. Whereas all C subjects had PRL responses to both tests,4/12 0 pts had no response to IV1T;O had lower PRL at 30mins after IVIT,5.4+0.7 12.9f3.7ngl ml, p<O.OS,and lower PRL at 60min.after IVTT,9.9f1 Urinary N-acetyl-beta-D-glucosaminidase(U~~~), a proximal tubular lysosomal enzyme, has been positively correlated with albumin excretion(Ualb).
after IET were lower than in C, 6.l*l-l= 12.7*3.7ng/ ml, pC0.05. Whereas all C subjects had PRL responses to both tests,4/12 0 pts had no response to IV1T;O had lower PRL at 30mins after IVIT, 5.4+0.7 12.9f3.7ngl ml, p<O.OS,and lower PRL at 60min.after IVTT,9.9f1.7 vs 20.4+5.9ng/ml, p(0.05.
Max PRL after IVTT was lower -in 0 pts,9.9f2.0 28.8f10.9, p40.05.MaxPRLafterIVIT was lower in 0 pts,6.2f4.1 28.9k18.3. No sex difference in PRL was noted with either test in both groups. Thus, blunted PRL secretion in CO suggests impaired hypothalamic function.
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Urinary N-acetyl-beta-D-glucosaminidase(U~~~), a proximal tubular lysosomal enzyme, has been positively correlated with albumin excretion(Ualb).
Since increased Ualb after exercise has been suggested to be an early indicator of nephropathy, UNAG and Ualb were measured before and 10 mins after treadmill exercise in 19 insulin dependent diabetic children and 21 age-matched controls. Patients exercised until exhaustion; HR, BP and EKG tracings were monitored at 3-min intervals. UNAG was measured using a spectrophometric assay with p-nitrophenol as the measured end-product. Ualb was measured by nephelometry; both were expressed per mgm/dl creatinine. HR and BP did not differ between the two groups before or after exercise.
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LHRHa suppresses gonadarche in girls with CPP, but little information is available regarding the response of males to this therapy. Four boys with CPP received LHRH, for 12 consecutive months. Prior to therapy, the patients had Tanner stage 11-IV pubertal development, a mean testicular volume of 16+3 (SE) ml, a chronologic age of 7.7t0.6 years and a bone age of 12.9+0.4 years. Following therapy, 3/4 boys demonstrated regression of secondary sex characteristics and all had a marked decrease in testicular size to 7+1 ml. Bone age advanced 4.5f0.5 months during 12 months of exposure to LHRH,. The pretreatment pubertal growth velocity of 13.5+2.7 cm/yr fell significantly to 5.5f.13 cm/yr over the year of therapy. Predicted height was increased to 3.84t2.24 cm. Endocrinoloqic parameters are summarized below: TI p<.01 l=plasma testosterone (ng%) in a PM pool; 2=mean of 8h pulsation study (mIU/ml LER 907); ~=AFSH or ALH after LHRH (2.5 mcg/kg sc) .
In boys with CPP, LHRH, is capable of: 1) reversing the clinical features of precocity, 2) abolishing the pulsatile release of gonadotropins with subsequent suppression of testosterone production, and 3) retarding skeletal maturation, slowing growth velocity, and improving predicted adult stature. 
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We have shown that the ratio of bioactive to inmunoreactive LH increases during puberty. To test whether this change is in the immuno-or biopotency of LH, we tested dose-response characteristics in both assays. Results: 1) In the bioassay (RIcT), the dose-response characteristics of basal and GnRH-stimulated plasma samples from pubertal (PUB) and adult subjects and the LER-907 and 1-1 standards were parallel; prePUB basal and GnRH-stimulated samples were less steep (-0.75 v. -1.00, pC0.05). Turner syndrome samples had slopes 8% greater. 2) Using an RIA with a bioactive '"1-~LH and NIADDK antiserum we found that the doseresponse relationship of plasma I-LH changes through puberty. The logit-log transformed dose-response curve for LER-907 was less steep than 1-1 (-0.73 v. -1.05, p<0.05); potency estimates at the extremes of the standard curves differed bv a factor of 1.7. There was no difference in slopes before and after GnRH infusion, but 7/14 prePUB samples, 3/14 PUB and 0115 adult were parallel to LER-907, while 1/14 prePUB, 6/14 PUB and 12/15 adult were parallel to 1-1. Turner syndrome samples had slopes similar to prePUB samples NS) .
Changing LH RIA dose-response characteristics is the principal factor in the changing ratio of bioactivity to immunoreactivity during puberty. This may reflect the structural heterogeneity of LH. Previously we have used time series analysis techniques to determine the ultradian pulsatile secretory rhythms of plasma gonadotropin (and testosterone) secretion in male monkeys during sexual development (JCEM 56:1214 (JCEM 56: & 1227 (JCEM 56: , 1983 as well as monthly urinary gonadotropin rhythms in premenarchal girls (Science 190: 161, 1975 ). Here we utilized this methodology to determine whether prepubertal and pubertal boys have gonadotropin cycles greater than one day duration. Ten healthy boys (4 prepubertal and 6 pubertal), ages 10 4/12 to 15 2/12, volunteered to collect timed nocturnal and first morning urine specimens for at least 2 months (consecutive series of daily urine collections varied from 62 to 78 days). The urinary gonadotropins were precipitated with acetone after pH adjustment with acetic acid. Precipitates, containing both LH and FSH, were dissolved in buffer and measured by specific radioinmunoassay. Mean LH secretion was 1. We found that intra-adrenal concentrations of most steroids are 2-10 times higher in adults than in infants, and reach levels (10-~-10-~ M) which might influence steroidogenic efficiency. Since 33-HSD and 17,20-desmolase act on 170H-pregnenolone to determine relative DHA and cortisol production during human development, we studied their kinetics in adrenal microsomes from 6 kidney donors (12-40 yr) and the effect of varying steroid concentrations on their activities. There was no age-related change in & for 33-HSD (0.1-0.5 uM) or desmolase (0.2-1.7 vM). At all ages Vmax for 33-HSD (3-8 nmol/mg/min) exceeded that for desmolase (0.3-1.4 nnol/mg/min). Physiological intra-adrenal concentrations (10-6 M) of progesterone, 17011-prog., 11-desoxycortisol, corticosterone, androstenedione and testosterone caused >20% inhibition of 30-HSD, with no effect on desmolase. Estradiol and estrone caused >95% inhibition of 30-HSD with only minimal impact on desmolase. Kinetic analysis showed competitive and non-competitive inhibition with Ki values of 10-7-10-5 M. These data demonstrate that ambient steroids can render 30-HSD ratelimiting and permit desmolase to compete for 170H-pregnenolone substrate. W i s phenomenon provides a rational explanation both for the relative 33-HSD deficiency of the human fetus and the increased C-19 steroid production during adrenarche.
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